Trump Reschedules Cannabis to Schedule 3, Opening Access and Research
CNBC TelevisionJanuary 5, 20261 min680 views
4 connections·6 entities in this video→Rescheduling of Cannabis
- 🗓️ President Trump signed an executive order to reschedule cannabis from a Schedule 1 to a Schedule 3 drug.
- 💊 This reclassification aligns cannabis with drugs like Tylenol with codeine and steroids, acknowledging its medical benefits.
Implications for Research and Investment
- 🔬 The rescheduling is expected to open up access to medical research for cannabis.
- 💰 It will also allow more investment to flow into the cannabis industry.
- 💸 Companies selling cannabis will be able to take basic tax deductions previously unavailable to them.
Medicare Pilot Program for Seniors
- 🩺 Dr. Oz announced a Medicare pilot program aimed at providing access to CBD for qualifying seniors.
- 👵 This initiative is part of a larger effort to increase access to the drug for specific demographics.
Industry Impact
- 🚀 These moves represent a massive shift for the cannabis industry, potentially marking a significant turning point after 50 years.
- 📈 The announcement has already caused significant movement in cannabis stocks.
Knowledge graph6 entities · 4 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover · drag to explore
6 entities
Chapters1 moments
Key Moments
Transcript4 segments
Full Transcript
Topics9 themes
What’s Discussed
Cannabis ReschedulingSchedule 3 DrugMedical ResearchCannabis StocksMedicare Pilot ProgramCBD AccessExecutive OrderTax DeductionsCannabis Industry
Smart Objects6 · 4 links
Concepts· 4
Event· 1
Person· 1